Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    Omalizumab good at preventing food allergies after accidental exposure

    Omalizumab good at preventing food allergies after accidental exposure

    Medha Baranwal Baranwal16 Aug 2018 8:10 PM IST
    Omalizumab may be a breakthrough therapy for preventing food allergies and consequent reactions after accidental exposure of offending foods.The U.S....
    Midazolam Nasal Spray may be available soon for treating  Seizure Clusters

    Midazolam Nasal Spray may be available soon for treating Seizure Clusters

    Vinay Singh singh16 Aug 2018 7:28 PM IST
    The U.S. Food and Drug Administration (FDA) has accepted for the review of a New Drug Application (NDA) for midazolam nasal spray, an investigational...
    First new upfront treatment Unresectable Liver Cancer

    First new upfront treatment Unresectable Liver Cancer

    Dr. Kamal Kant Kohli Kohli16 Aug 2018 7:05 PM IST
    Lenvatinib capsules have been approved (Lenvima, Eisai Inc.) as first-line treatment of patients with unresectable Liver Cancer or hepatocellular...
    Transcranial magnetic stimulation may be new treatment of OCD

    Transcranial magnetic stimulation may be new treatment of OCD

    Hina Zahid17 Aug 2018 7:15 PM IST
    Brainsway Deep Transcranial Magnetic Stimulation System has been approved for marketing for treatment of obsessive-compulsive disorder (OCD) by the...
    New minimally-invasive, non drug therapy for Pain Management

    New minimally-invasive, non drug therapy for Pain Management

    Vinay Singh singh21 Aug 2018 7:25 PM IST
    The SPRINT System is the only percutaneous PNS System cleared by the FDA and indicated for up to 60 days in the back and/or extremities for both...
    Oxervate is the first ever topical eye drop for neurotrophic keratitis

    Oxervate is the first ever topical eye drop for neurotrophic keratitis

    Dr. Kamal Kant Kohli Kohli22 Aug 2018 7:32 PM IST
    The first drug, Oxervate (cenegermin) has been approved for the treatment of neurotrophic keratitis by the U.S. Food and Drug Administration. The...
    Loteprednol - New Topical Steroid for Post surgery Eye Pain

    Loteprednol - New Topical Steroid for Post surgery Eye Pain

    Vinay Singh singh26 Aug 2018 7:05 PM IST
    Loteprednol etabonate ophthalmic suspension (Inveltys) 1% is new topical steroid preparation that has bagged approval from U.S Food and Drug...
    Weight Loss drug Lorcaserin safe, has no cardiac toxicity-ESC update

    Weight Loss drug Lorcaserin safe, has no cardiac toxicity-ESC update

    Vinay Singh singh28 Aug 2018 7:25 PM IST
    Lorcaserin, a drug approved for weight loss in overweight and obese patients does not increase the risk of cardiovascular events, according to the...
    Eravacycline-Latest antibiotic for complicated intra-abdominal infections

    Eravacycline-Latest antibiotic for complicated intra-abdominal infections

    Vinay Singh singh29 Aug 2018 8:28 PM IST
    Xerava, Eravacycline injection secured approval from the US Food and Drug Administration (FDA) for the treatment of complicated intra-abdominal...
    SGLT2 inhibitors may cause Fourniers gangrene of genital area in diabetics : FDA warns

    SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns

    Hina Zahid31 Aug 2018 8:35 PM IST
    The Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
    FDA Approves Two New Oral Treatments for HIV-1 Infection

    FDA Approves Two New Oral Treatments for HIV-1 Infection

    Vinay Singh singh1 Sept 2018 7:28 PM IST
    The US Food and Drug Administration (FDA) has approved two new HIV-1 medicines: DELSTRIGO™, a once-daily fixed-dose combination tablet of doravirine...
    Brexanolone lifts postpartum depression within days: Lancet

    Brexanolone lifts postpartum depression within days: Lancet

    Medha Baranwal Baranwal2 Sept 2018 8:25 PM IST
    An integrated analysis of multi-site phase 2 and 3 trials of brexanolone injection are not only promising but could evolve the treatment of postpartum...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok